Seeing the light (chains): a paradigm shift in PGNMID

2025/11/19 by Jean Hou, Mark Haas · 1 voice
Biochemistry, Genetics and Molecular Biology · Medicine · #Amyloidosis: Diagnosis, Treatment, Outcomes #Renal Diseases and Glomerulopathies #Vasculitis and related conditions

paper · doi:10.1016/j.kint.2025.09.018

openalex publication_date 2025/11/19 · openalex created_date 2025/11/19 · crossref created 2025/11/19 · crossref issued 2025/12/01 · crossref published 2025/12/01 · crossref published-print 2025/12/01 · crossref deposited 2026/05/28 · crossref indexed 2026/05/28 · openalex updated_date 2026/06/21

Citations

• Renal Pathology Society/International Kidney and Monoclonal Gammopathy Research Group consensus on pathologic definitions and terminology of monoclonal gammopathy–associated kidney lesions

Discussions

• Commentary Seeing the light (chains): a paradigm shift in PGNMID Jean Hou and Mark Haas doi.org/10.1016/j.kint.2025.09.018 Original article: doi.org/10.1016/j.kint.2025.07.039 #NephSky #MedSky # [bsky, 1 points, 0 comments]